Cytokinetics
S&P 400
$73.77
+0.20%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of -1.66.
- Return on equity is healthy at 452.5%.
- Current assets comfortably cover current liabilities (current ratio 4.53).
!Watch-points
- Thin interest cover: operating profit covers interest only about -13.4 times.
- Return on capital employed is on the lower side at -35.6%.
- The company reported a net loss in the latest period.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
-1.63
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Piotroski F-ScoreWeak
2 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$10.26B
Current Price$ 73.77
High / Low$ 88.31 / 47.22
Stock P/E-11.28
Book Value$ -1,313.44
Dividend Yield0%
ROCE-35.55%
ROE452.46%
Debt to Equity-1.66
Current Ratio4.53
P/B Ratio-59.016
EPS$ -6.54
Debt$287.57M
PAT Margin-891.60%
Cash PAT$-774.83M
ICR-13.43